The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States
Open accessAbstract
The Infectious Diseases Society of America advocates trimethoprim-sulfamethoxazole (SXT) as initial therapy for females with acute uncomplicated bacterial cystitis in settings where the prevalence of SXT resistance does not exceed 10 to 20%. To determine trends in the activities of SXT, ampicillin, ciprofloxacin, and nitrofurantoin among urine isolates of Escherichia coli from female outpatients, susceptibility testing data from The Surveillance Network (TSN) Database-USA ( n = 286,187) from 1995 to 2001 were analyzed. Resistance rates among E. coli isolates to ampicillin (range, 36.0 to 37.4% per year), SXT (range, 14.8 to 17.0%), ciprofloxacin (range, 0.7 to 2.5%), and nitrofurantoin (range, 0.4 to 0.8%) varied only slightly over this 7-year period. Ciprofloxacin was the only agent studied that demonstrated a consistent stepwise increase in resistance from 1995 (0.7%) to 2001 (2.5%). In 2001, SXT resistance among E. coli isolates was >10% in all nine U.S. Bureau of the Census regions. At institutions testing ≥100 urinary isolates of E. coli ( n = 126) in 2001, ampicillin (range, 27.3 to 98.8%) and SXT (range, 7.5 to 47.1%) resistance rates varied widely while ciprofloxacin (range, 0 to 12.9%) and nitrofurantoin (range, 0 to 2.8%) resistance rates were more consistent. In 2001, the most frequent coresistant phenotypes were resistance to ampicillin and SXT (12.0% of all isolates; 82.3% of coresistant isolates) and resistance to ampicillin, ciprofloxacin, and SXT (1.4% of all isolates; 9.9% of coresistant isolates). Coresistance less frequently included resistance to nitrofurantoin (3.5% of coresistant isolates) than resistance to ciprofloxacin (15.8%), SXT (95.7%), and ampicillin (98.1%). In conclusion, among urinary isolates of E. coli from female outpatients in the United States, national resistance rates to SXT were relatively consistent (14.8 to 17.0%) from 1995 to 2001 but demonstrated considerable regional and institutional variation in 2001. Therapies other than SXT may need to be considered in some locations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
The epidemiology of urinary tract infection
Foxman, B. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.190 · Cited by 1,771
Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J., & Stamm, W. E. (1999) · Clinical Infectious Diseases · doi:10.1086/520427 · Cited by 1,188
Urinary Tract Infections: Disease Panorama and Challenges
Stamm, W. E., & Norrby, S. R. (2001) · The Journal of Infectious Diseases · doi:10.1086/318850 · Cited by 825
DIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION
Hooton, T. M., & Stamm, W. E. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70373-1 · Cited by 751
Gupta, K., Hooton, T. M., & Stamm, W. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-1-200107030-00012 · Cited by 677
Gupta, K. (1999) · JAMA · doi:10.1001/jama.281.8.736 · Cited by 609
Manges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 531
Gupta, K., Sahm, D. F., Mayfield, D., & Stamm, W. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320880 · Cited by 359
Self-citationSahm, D. F., Thornsberry, C., Mayfield, D. C., Jones, M. E., & Karlowsky, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1402-1406.2001 · Cited by 294
Self-citationMcOsker, C. C., & Fitzpatrick, P. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.suppl_a.23 · Cited by 268
Goettsch, W. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.223 · Cited by 267
Raz, R., Chazan, B., Kennes, Y., Colodner, R., Rottensterich, E., Dan, M., Lavi, I., Stamm, W., & the Israeli Urinary Tract Infection Group (2002) · Clinical Infectious Diseases · doi:10.1086/339812 · Cited by 221
Mathai, D., Jones, R. N., & Pfaller, M. A. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00254-1 · Cited by 216
Sahm, D. F., Marsilio, M. K., & Piazza, G. (1999) · Clinical Infectious Diseases · doi:10.1086/520195 · Cited by 213
Self-citationZhanel, G. G., Karlowsky, J. A., Harding, G. K. M., Carrie, A., Mazzulli, T., Low, D. E., The Canadian Urinary Isolate Study Group, & Hoban, D. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1089-1092.2000 · Cited by 190
Self-citationHuang, E. S., & Stafford, R. S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.1.41 · Cited by 155
Jones, R. N., Kugler, K. C., Pfaller, M. A., & Winokur, P. L. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00158-8 · Cited by 151
Gupta, K., Hooton, T. M., Wobbe, C. L., & Stamm, W. E. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00035-7 · Cited by 125
Demographic, Clinical, and Treatment Parameters Influencing the Outcome of Acute Cystitis
ECHOLS, R. M., Tosiello, R. L., Haverstock, D. C., & Tice, A. D. (1999) · Clinical Infectious Diseases · doi:10.1086/520138 · Cited by 104
Karlowsky, J. A., Jones, M. E., Thornsberry, C., Critchley, I. A., Kelly, L. J., & Sahm, D. F. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00369-7 · Cited by 97
Self-citationShort-course therapy of acute cystitis: a brief review of therapeutic strategies
Tice, A. D. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.suppl_1.85 · Cited by 93
Le, T., & Miller, L. G. (2001) · Clinical Infectious Diseases · doi:10.1086/322603 · Cited by 89
Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., Evangelista, A. T., Critchley, I. A., & Sahm, D. F. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00466-6 · Cited by 88
Self-citationSahm, D. F., Critchley, I. A., Kelly, L. J., Karlowsky, J. A., Mayfield, D. C., Thornsberry, C., Mauriz, Y., & Kahn, J. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.267-274.2001 · Cited by 88
Self-citationUSA resistance patterns among UTI pathogens
Thomson, K. S., Sanders, W. E., & Sanders, C. C. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.suppl_a.9 · Cited by 62
Talan, D. A., Stamm, W. E., Hooton, T. M., Moran, G. J., Burke, T., Iravani, A., Reuning-Scherer, J., & Church, D. A. (2000) · JAMA · doi:10.1001/jama.283.12.1583
Cited by
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
The epidemiology of urinary tract infection
Foxman, B. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.190 · Cited by 1,771
Mechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
Mechanisms of antimicrobial resistance in bacteria
Tenover, F. C. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.219 · Cited by 637
Bryce, A., Hay, A. D., Lane, I. F., Thornton, H. V., Wootton, M., & Costelloe, C. (2016) · BMJ · doi:10.1136/bmj.i939 · Cited by 416
Metadata
- Authors
- Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., & Sahm, D. F.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-08
- Volume
- 46
- Issue
- 8
- Pages
- 2540-2545
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2113664107
- Cited by
- 367
- References
- 27
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.